FDA Drug recall D-128-2013
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
- FDA Drug
- Class III
- terminated
- Published 2013-01-23
On 2013-01-23 the FDA classified a Class III recall of CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88 by Teva Pharmaceuticals Usa, citing impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-128-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-04-24 |
| Published | 2013-01-23 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Reason
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Identifiers
| ndc | 0093-5420-88 |
|---|---|
| code_info | Lot number 6A007046V, exp 07/12 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-128-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.